NCT00734045View on ClinicalTrials.gov

Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Congestive Heart Failure (CHF)
Trial Locations (2)

92161

US Department of Veteran's Affairs, San Diego

94110

San Francisco General Hospital, San Francisco

Sponsors

Lead Sponsor

Nanogen, Inc.
All Listed Sponsors
lead

Nanogen, Inc.

INDUSTRY

NCT00734045 - Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples | Biotech Hunter | Biotech Hunter